Virology Testing Market Report 2026

The virology testing market size has grown rapidly in recent years. It will grow from $5.8 billion in 2025 to $6.41 billion in 2026 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing prevalence of viral infections, expansion of hospital diagnostic infrastructure, rising adoption of PCR-based testing, growth of centralized diagnostic laboratories, improved availability of assay kits.

The virology testing market size is expected to see rapid growth in the next few years. It will grow to $9.86 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing demand for point-of-care virology testing, rising investments in molecular diagnostics, expansion of personalized medicine approaches, growing use of multiplex testing platforms, increasing focus on early disease detection. Major trends in the forecast period include increasing adoption of molecular diagnostic testing, rising use of high-throughput pcr platforms, growing integration of automated assay systems, expansion of syndromic testing panels, enhanced focus on rapid and accurate results.

The rising incidence of viral infections is expected to drive the growth of the virology testing market going forward. Viral infections are diseases caused by viruses, which are microscopic infectious agents made up of genetic material (DNA or RNA) encased in a protein coat. Virology testing plays a critical role in accurate diagnosis, surveillance, research, and public health preparedness. It enables the detection of viral pathogens, informs treatment decisions, monitors the spread of infections, and supports the development of new interventions. The growing need for virology testing is driven by the necessity to manage viral infections and mitigate their impact effectively. For instance, in September 2024, according to GOV.UK, a UK-based government services and information provider, between week 40 of 2023 and week 14 of 2024 in England, where virological testing results were available, 708 incidents (53.3%) were confirmed as SARS-CoV-2, followed by 472 incidents of influenza (35.5%), 68 incidents of RSV (5.1%), and 80 incidents (6%) involving other viruses. Therefore, the rising incidence of viral infections is boosting the growth of the virology testing market.

Major companies operating in the virology testing market are focusing on advanced solutions such as agar gel precipitation test solutions to meet the increasing demand for precise diagnostic tools. Advanced agar gel precipitation test solutions are specialized preparations used for detailed immunological analyses to detect and characterize antigen-antibody interactions. For instance, in May 2023, Creative Diagnostics, a US-based biotechnology company, launched a new single radial immunodiffusion testing service designed for the biological industry, simplifying the process for researchers to accurately measure antigen concentrations in samples. Using the well-established agar gel precipitation technique, the service employs antibodies with defined specificity uniformly distributed within the agar gel. Samples containing the target antigen are placed in wells within the gel, allowing the antigen to diffuse radially, forming a distinct precipitate ring that indicates the equilibrium point between antigens and antibodies. By measuring the diameter of this ring and comparing it against a standard curve, the service provides precise antigen concentration data, offering researchers valuable quantitative insights.

In April 2025, Source BioScience UK Ltd, a UK-based healthcare technology company, acquired Cambridge Clinical Laboratories for an undisclosed amount. This acquisition enables Source BioScience to strengthen its clinical diagnostics portfolio by offering end-to-end preclinical and clinical testing services. Cambridge Clinical Laboratories is a UK-based healthcare technology company specializing in personalized diagnostic services across oncology, virology, men’s health, gastroenterology, fertility, and validation studies for clinical research.

Major companies operating in the virology testing market are Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Eurofins Scientific SE, Agilent Technologies Inc., Grifols S.A., Hologic Inc., bioMerieux SA, Bio-Rad Laboratories Inc., Qiagen NV, Cepheid Inc., Eiken Chemical Co Ltd., DiaSorin SpA, Fujirebio Diagnostics Inc., Microbac Laboratories Inc., Trinity Biotech plc, Diamedix Corporation, Vircell SL.

North America was the largest region in the virology testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virology testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the virology testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the virology testing market by increasing costs of imported diagnostic instruments, reagents, assay kits, and electronic components used in PCR machines and analyzers. Hospitals and laboratories in North America and Europe are most affected due to reliance on imported diagnostic technologies, while Asia-Pacific faces cost pressures on test kit manufacturing. These tariffs are increasing testing costs and delaying laboratory upgrades. However, they are also encouraging domestic reagent production, localized instrument assembly, and regional expansion of diagnostic manufacturing capabilities.

The virology testing market research report is one of a series of new reports that provides virology testing market statistics, including virology testing industry global market size, regional shares, competitors with a virology testing market share, detailed virology testing market segments, market trends and opportunities, and any further data you may need to thrive in the virology testing industry. This virology testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Virology testing involves diagnosing viral infections by detecting viruses or specific viral components in biological samples such as blood, saliva, or tissue. These tests are used to identify, monitor, and manage viral diseases.

The main types of virology testing include instruments, assay kits, and consumables. Instruments refer to specialized equipment and devices used to perform various diagnostic tests and procedures. Techniques such as molecular diagnostics, immunoassays, mass spectrometry, and others are applied for conditions including skin and soft tissue infections, respiratory tract infections, gastrointestinal tract infections, urinary tract infections, eye infections, sexually transmitted diseases, and perinatal infections. These tests are utilized by hospitals, clinics, laboratories, diagnostic centers, blood banks, and pharmacies.

The virology testing market consists of revenues earned by entities by providing services such as comprehensive viral screening, virucidal disinfectant efficacy testing, virus research, and testing for infectious disease agents. The market value includes the value of related goods sold by the service provider or included within the service offering. The virology testing market also includes sales of virology test kits, polymerase chain reaction (PCR) instruments, and enzyme-linked immunosorbent assay (ELISA) kits, which are used in providing virology testing services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.